The 2003 Oolong Diabetes Trial Was Led From a Tea Maker

The oolong blood sugar trial cited by name was led by an author from the research center of a company that sells oolong tea. A second trial, in healthy men, found nothing. A cohort of nearly 5,000 workers found heavier oolong drinkers developed diabetes at a higher rate. The chemistry behind the claim checks out in a test tube. Whether it does anything reliable in a person is still an open question.

The trial with the striking numbers

In a 2003 crossover trial published in Diabetes Care, 20 patients with type 2 diabetes drank 1,500 milliliters of oolong tea a day, about six cups, for 30 days, and water for 30 days, after 14 days without tea (Hosoda et al., 2003¹). On the tea, plasma glucose fell from 229 to 162.2 milligrams per deciliter, and fructosamine, a marker of blood sugar control over the preceding two to three weeks, fell from 409.9 to 323.3 micromoles per liter. Both drops were statistically significant. On water, neither number changed significantly.

A near-30-percent drop in fasting glucose, in patients already on oral diabetes medication, is a large effect for a beverage.

Read the author list, not just the abstract

The trial's lead author was affiliated with the Research Center of Suntory, an Osaka beverage company; the byline also runs through a Taiwan hospital, a Taiwan university nutrition department, and a Japanese medical school. It does mean the trial that established the headline number was led from a company that sells oolong tea. A 20-person crossover trial with a corporate lead author and no independent replication of its own specific dose and population is a starting point for a hypothesis, not a settled finding.

A trial in healthy men found nothing

A 2011 crossover study from the United States Department of Agriculture's own nutrition research center, sharing one co-author with the 2003 trial and funded by the USDA and Suntory, gave 19 healthy men five days each of oolong tea, oolong tea supplemented with added catechins, oolong tea supplemented with other tea polyphenols, or a caffeinated or plain water control, then measured fasting glucose, fasting insulin, and the full blood sugar response to a test dose of glucose (Baer et al., 2011²). None of the tea conditions, plain or fortified, produced any measurable improvement over water on any of those measures.

Hosoda's subjects already had diabetes and drank six cups a day for a month; Baer's were healthy men on five days of tea.

What the systematic reviewers actually concluded

The most complete answer so far comes from a 2019 network meta-analysis in Nutrients that pooled every eligible trial of coffee and tea against glucose outcomes (Kondo et al., 2019³). Only two trials qualified for oolong specifically, and the pooled network estimate showed a real-looking drop in fasting glucose, 39.91 milligrams per deciliter. The authors graded the evidence behind that number "very low quality," citing unclear allocation concealment in both trials and a potential financial bias: both of the oolong trials in their pool were supported by oolong tea manufacturers. Run a simpler, more conservative comparison across the same two studies, a direct pairwise meta-analysis rather than the network model, and the effect stopped being statistically significant at all.

The chemistry is not in dispute; what it adds up to in a person is

Set the human trials aside and the laboratory chemistry is on firmer ground. Oolong's catechins, EGCG and ECG in particular, inhibit alpha-glucosidase, the gut enzyme that breaks starch down into absorbable glucose, by binding the enzyme's active site. A 2024 study in Foods measured this directly in Fenghuang Dancong, the Guangdong cultivar traditionally linked to Phoenix Mountain but here grown in Meizhou, testing leaf harvested in all four seasons of 2022 (Wen et al., 2024⁴). Winter and spring leaf inhibited the enzyme most strongly; summer and autumn leaf, lower in catechins, inhibited it least. In mice given a starch dose alongside the isolated catechins, EGCG slowed the rise in blood glucose over the following two hours most, followed by ECG.

That is a genuine, mechanistic reason a cup of oolong could slow how fast a meal's starch turns into blood sugar. It is also, notably, an in vitro and mouse result, not a demonstrated effect in a person eating a normal meal. A real mechanism does not guarantee a clinically meaningful effect at ordinary drinking levels.

The finding that runs the other way

A prospective cohort from Japan's HIPOP-OHP study tracked 4,975 male workers from 1999 to 2004 and recorded 201 new diabetes diagnoses over a median 3.4 years (Hayashino et al., 2011⁵). Compared with men who drank no oolong, the hazard ratio for developing diabetes was 1.00 for one cup a day and 1.64 for two or more cups a day. The heaviest oolong drinkers in the cohort developed diabetes at a 64 percent higher rate than non-drinkers, with fasting glucose rising faster year over year as reported consumption increased.

The authors do not claim oolong causes diabetes. An observational cohort like this cannot separate cause from confounding: heavier tea drinkers in a Japanese worker cohort may differ in diet, workload, sleep, or existing metabolic risk in ways the study could not fully control for.

Tea in general fares better than oolong in particular

Zoom out to tea as a category and the picture brightens. A 2014 dose-response meta-analysis pooling sixteen cohorts and 545,517 participants found that each additional two cups of tea a day predicted a 4.6 percent lower rate of type 2 diabetes (Yang et al., 2014⁶). That is a real, if modest, protective association, but it pools green, black, and oolong tea together rather than isolating oolong's own effect, so it cannot settle the oolong-specific question the way it might first appear to.